StreetInsider.com News Articles

Form 4 Embecta Corp. For: Jun 01 Filed by: Roth Anthony M.

Tue, 02 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260602/26592923.html

Form 4 Embecta Corp. For: Jun 01 Filed by: Roth Anthony M.

Tue, 02 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260602/26592923.html

embecta to Participate in Investor Events

Mon, 01 Jun 2026 17:00:00 -0400

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

2026 Jefferies Global Healthcare Conference

Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.

TD Cowen Diabetes Tech Summit

Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET,

embecta to Participate in Investor Events

Mon, 01 Jun 2026 17:00:00 -0400

2026 Jefferies Global Healthcare Conference

Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.

TD Cowen Diabetes Tech Summit

Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET,

embecta to Participate in Investor Events

Mon, 01 Jun 2026 17:00:00 -0400

2026 Jefferies Global Healthcare Conference

Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.

TD Cowen Diabetes Tech Summit

Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET,

embecta to Participate in Investor Events

Mon, 01 Jun 2026 17:00:00 -0400

2026 Jefferies Global Healthcare Conference

Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.

TD Cowen Diabetes Tech Summit

Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET,

Form SCHEDULE 13G/A Embecta Corp. Filed by: River Road Asset Management, LLC

Wed, 27 May 2026 11:26:00 -0400

si-local-file:///var/storage/secattach/20260527/26555687.html

Form SCHEDULE 13G/A Embecta Corp. Filed by: River Road Asset Management, LLC

Wed, 27 May 2026 11:26:00 -0400

si-local-file:///var/storage/secattach/20260527/26555687.html

Form SD Embecta Corp.

Fri, 22 May 2026 10:37:00 -0400

si-local-file:///var/storage/secattach/20260522/26539673.html

Form SD Embecta Corp.

Fri, 22 May 2026 10:37:00 -0400

si-local-file:///var/storage/secattach/20260522/26539673.html

Form 8-K Embecta Corp. For: May 15

Fri, 15 May 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260515/26500646.html

Form 8-K Embecta Corp. For: May 15

Fri, 15 May 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260515/26500646.html

embecta completes acquisition of Owen Mumford for £100 million

Fri, 15 May 2026 09:00:53 -0400

Embecta Corp. (NASDAQ: EMBC) completed its acquisition of Owen Mumford Holdings Limited, a UK-based medical device manufacturer, according to a company statement.

The transaction involved an upfront cash payment of £100 million with up to an additional £50 million in performance-based payments tied to net sales of Owen Mumford's Aidaptus auto-injector platform over three years following the closing.

Embecta and Owen Mumford announced the definitive agreement on March 19, 2026. The acquisition adds Owen Mumford's drug delivery technologies and medical device portfolio to Embecta's operations.

Owen Mumford, founded in 1952 and based in Oxfordshire, develops drug delivery technologies for pharmaceutical and biotechnology companies.

embecta completes acquisition of Owen Mumford for £100 million

Fri, 15 May 2026 09:00:53 -0400

Embecta Corp. (NASDAQ: EMBC) completed its acquisition of Owen Mumford Holdings Limited, a UK-based medical device manufacturer, according to a company statement.

Embecta and Owen Mumford announced the definitive agreement on March 19, 2026. The acquisition adds Owen Mumford's drug delivery technologies and medical device portfolio to Embecta's operations.

Owen Mumford, founded in 1952 and based in Oxfordshire, develops drug delivery technologies for pharmaceutical and biotechnology companies.

embecta completes acquisition of Owen Mumford for £100 million

Fri, 15 May 2026 09:00:53 -0400

Embecta Corp. (NASDAQ: EMBC) completed its acquisition of Owen Mumford Holdings Limited, a UK-based medical device manufacturer, according to a company statement.

Embecta and Owen Mumford announced the definitive agreement on March 19, 2026. The acquisition adds Owen Mumford's drug delivery technologies and medical device portfolio to Embecta's operations.

Owen Mumford, founded in 1952 and based in Oxfordshire, develops drug delivery technologies for pharmaceutical and biotechnology companies.

embecta completes acquisition of Owen Mumford for £100 million

Fri, 15 May 2026 09:00:53 -0400

Embecta Corp. (NASDAQ: EMBC) completed its acquisition of Owen Mumford Holdings Limited, a UK-based medical device manufacturer, according to a company statement.

Embecta and Owen Mumford announced the definitive agreement on March 19, 2026. The acquisition adds Owen Mumford's drug delivery technologies and medical device portfolio to Embecta's operations.

Owen Mumford, founded in 1952 and based in Oxfordshire, develops drug delivery technologies for pharmaceutical and biotechnology companies.

embecta Completes Acquisition of Owen Mumford Holdings Limited